Healthcare | June 12, 2022
Karkinos Healthcare launched ‘Advanced Center for Cancer Diagnostics and Research’
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
Cantourage introduces second Clever Leaves medical cannabis product to the German market
The new subsidiary follows the recent announcement of Tetra's partnership with Cannvalate Pty Ltd for the performance of clinical trials of Tetra's drug candidates in Australia.
The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
Investment with representation on the Board of Directors and technical know-how
Revolutionary ovarian cancer rapid test available Q4 2022
CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng
RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
